{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:53:36Z","timestamp":1794610416308,"version":"4.9.1"},"publisher-location":"New York, NY","reference-count":32,"publisher":"Springer New York","isbn-type":[{"value":"9781493997930","type":"print"},{"value":"9781493997947","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T00:00:00Z","timestamp":1567641600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-1-4939-9794-7_3","type":"book-chapter","created":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T15:03:29Z","timestamp":1567609409000},"page":"31-49","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tumor Targeting of Oncolytic Adenoviruses Using Bispecific Adapter Proteins"],"prefix":"10.1007","author":[{"given":"Julia","family":"Niemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"K\u00fchnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,5]]},"reference":[{"key":"3_CR1","doi-asserted-by":"publisher","first-page":"19976","DOI":"10.18632\/oncotarget.5116","volume":"6","author":"C Larson","year":"2015","unstructured":"Larson C, Oronsky B, Scicinski J, Fanger GR, Stirn M, Oronsky A, Reid TR (2015) Going viral: a review of replication-selective oncolytic adenoviruses. Oncotarget 6:19976\u201319989","journal-title":"Oncotarget"},{"key":"3_CR2","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1200\/JCO.2017.75.8219","volume":"36","author":"FF Lang","year":"2018","unstructured":"Lang FF, Conrad C, Gomez-Manzano C, Yung WKA, Sawaya R, Weinberg JS, Prabhu SS, Rao G, Fuller GN, Aldape KD et al (2018) Phase I study of DNX-2401 (delta-24-RGD) oncolytic adenovirus: replication and immunotherapeutic effects in recurrent malignant glioma. J Clin Oncol 36:1419\u20131427","journal-title":"J Clin Oncol"},{"key":"3_CR3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.274.5286.373","volume":"274","author":"JR Bischoff","year":"1996","unstructured":"Bischoff JR, Kirn DH, Williams A, Heise C, Horn S, Muna M, Ng L, Nye JA, Sampson-Johannes A, Fattaey A et al (1996) An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274:373\u2013376","journal-title":"Science"},{"key":"3_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/sj.onc.1203251","volume":"19","author":"J Fueyo","year":"2000","unstructured":"Fueyo J, Gomez-Manzano C, Alemany R, Lee PS, McDonnell TJ, Mitlianga P, Shi YX, Levin VA, Yung WK, Kyritsis AP (2000) A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo. Oncogene 19:2\u201312","journal-title":"Oncogene"},{"key":"3_CR5","doi-asserted-by":"publisher","first-page":"7763","DOI":"10.1038\/sj.onc.1209048","volume":"24","author":"D Ko","year":"2005","unstructured":"Ko D, Hawkins L, Yu DC (2005) Development of transcriptionally regulated oncolytic adenoviruses. Oncogene 24:7763\u20137774","journal-title":"Oncogene"},{"key":"3_CR6","doi-asserted-by":"publisher","first-page":"7802","DOI":"10.1038\/sj.onc.1209037","volume":"24","author":"M Aghi","year":"2005","unstructured":"Aghi M, Martuza RL (2005) Oncolytic viral therapies \u2013 the clinical experience. Oncogene 24:7802\u20137816","journal-title":"Oncogene"},{"key":"3_CR7","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","volume":"275","author":"JM Bergelson","year":"1997","unstructured":"Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW (1997) Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320\u20131323","journal-title":"Science"},{"key":"3_CR8","doi-asserted-by":"publisher","first-page":"7478","DOI":"10.1128\/JVI.79.12.7478-7491.2005","volume":"79","author":"DM Shayakhmetov","year":"2005","unstructured":"Shayakhmetov DM, Gaggar A, Ni S, Li ZY, Lieber A (2005) Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity. J Virol 79:7478\u20137491","journal-title":"J Virol"},{"key":"3_CR9","doi-asserted-by":"publisher","first-page":"5483","DOI":"10.1073\/pnas.0711757105","volume":"105","author":"O Kalyuzhniy","year":"2008","unstructured":"Kalyuzhniy O, Di Paolo NC, Silvestry M, Hofherr SE, Barry MA, Stewart PL, Shayakhmetov DM (2008) Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo. Proc Natl Acad Sci U S A 105:5483\u20135488","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3_CR10","first-page":"813","volume":"61","author":"JT Douglas","year":"2001","unstructured":"Douglas JT, Kim M, Sumerel LA, Carey DE, Curiel DT (2001) Efficient oncolysis by a replicating adenovirus (ad) in vivo is critically dependent on tumor expression of primary ad receptors. Cancer Res 61:813\u2013817","journal-title":"Cancer Res"},{"key":"3_CR11","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1158\/1078-0432.CCR-18-1089","volume":"24","author":"H Uusi-Kerttula","year":"2018","unstructured":"Uusi-Kerttula H, Davies JA, Thompson JM, Wongthida P, Evgin L, Shim KG, Bradshaw A, Baker AT, Rizkallah PJ, Jones R et al (2018) Ad5NULL-A20: a tropism-modified, alphavbeta6 integrin-selective oncolytic adenovirus for epithelial ovarian cancer therapies. Clin Cancer Res 24:4215\u20134224","journal-title":"Clin Cancer Res"},{"key":"3_CR12","doi-asserted-by":"crossref","first-page":"8221","DOI":"10.1128\/JVI.71.11.8221-8229.1997","volume":"71","author":"TJ Wickham","year":"1997","unstructured":"Wickham TJ, Tzeng E, Shears LL, Roelvink PW, Li Y, Lee GM, Brough DE, Lizonova A, Kovesdi I (1997) Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. J Virol 71:8221\u20138229","journal-title":"J Virol"},{"key":"3_CR13","first-page":"1266","volume":"62","author":"GJ Bauerschmitz","year":"2002","unstructured":"Bauerschmitz GJ, Lam JT, Kanerva A, Suzuki K, Nettelbeck DM, Dmitriev I, Krasnykh V, Mikheeva GV, Barnes MN, Alvarez RD et al (2002) Treatment of ovarian cancer with a tropism modified oncolytic adenovirus. Cancer Res 62:1266\u20131270","journal-title":"Cancer Res"},{"key":"3_CR14","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/jgm.285","volume":"4","author":"MK Magnusson","year":"2002","unstructured":"Magnusson MK, Hong SS, Henning P, Boulanger P, Lindholm L (2002) Genetic retargeting of adenovirus vectors: functionality of targeting ligands and their influence on virus viability. J Gene Med 4:356\u2013370","journal-title":"J Gene Med"},{"key":"3_CR15","first-page":"1262","volume":"63","author":"Y Kawakami","year":"2003","unstructured":"Kawakami Y, Li H, Lam JT, Krasnykh V, Curiel DT, Blackwell JL (2003) Substitution of the adenovirus serotype 5 knob with a serotype 3 knob enhances multiple steps in virus replication. Cancer Res 63:1262\u20131269","journal-title":"Cancer Res"},{"key":"3_CR16","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1099\/vir.0.81992-0","volume":"87","author":"P Henning","year":"2006","unstructured":"Henning P, Lundgren E, Carlsson M, Frykholm K, Johannisson J, Magnusson MK, Tang E, Franqueville L, Hong SS, Lindholm L et al (2006) Adenovirus type 5 fiber knob domain has a critical role in fiber protein synthesis and encapsidation. J Gen Virol 87:3151\u20133160","journal-title":"J Gen Virol"},{"key":"3_CR17","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.1128\/JVI.75.9.4176-4183.2001","volume":"75","author":"V Krasnykh","year":"2001","unstructured":"Krasnykh V, Belousova N, Korokhov N, Mikheeva G, Curiel DT (2001) Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin. J Virol 75:4176\u20134183","journal-title":"J Virol"},{"key":"3_CR18","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.ymthe.2005.11.019","volume":"13","author":"FH Schagen","year":"2006","unstructured":"Schagen FH, Wensveen FM, Carette JE, Dermody TS, Gerritsen WR, van Beusechem VW (2006) Genetic targeting of adenovirus vectors using a reovirus sigma1-based attachment protein. Mol Ther 13:997\u20131005","journal-title":"Mol Ther"},{"key":"3_CR19","doi-asserted-by":"publisher","first-page":"pii: E201","DOI":"10.3390\/cancers10060201","volume":"10","author":"AT Baker","year":"2018","unstructured":"Baker AT, Aguirre-Hernandez C, Hallden G, Parker AL (2018) Designer oncolytic adenovirus: coming of age. Cancers (Basel) 10:pii: E201","journal-title":"Cancers (Basel)"},{"key":"3_CR20","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.biomaterials.2017.12.008","volume":"158","author":"NT Martin","year":"2018","unstructured":"Martin NT, Wrede C, Niemann J, Brooks J, Schwarzer D, Kuhnel F, Gerardy-Schahn R (2018) Targeting polysialic acid-abundant cancers using oncolytic adenoviruses with fibers fused to active bacteriophage borne endosialidase. Biomaterials 158:86\u201394","journal-title":"Biomaterials"},{"key":"3_CR21","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1749-6632.1999.tb09409.x","volume":"886","author":"DT Curiel","year":"1999","unstructured":"Curiel DT (1999) Strategies to adapt adenoviral vectors for targeted delivery. Ann N Y Acad Sci 886:158\u2013171","journal-title":"Ann N Y Acad Sci"},{"key":"3_CR22","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/sj.cgt.7700198","volume":"7","author":"HJ Haisma","year":"2000","unstructured":"Haisma HJ, Grill J, Curiel DT, Hoogeland S, van Beusechem VW, Pinedo HM, Gerritsen WR (2000) Targeting of adenoviral vectors through a bispecific single-chain antibody. Cancer Gene Ther 7:901\u2013904","journal-title":"Cancer Gene Ther"},{"key":"3_CR23","doi-asserted-by":"publisher","first-page":"6875","DOI":"10.1128\/JVI.74.15.6875-6884.2000","volume":"74","author":"I Dmitriev","year":"2000","unstructured":"Dmitriev I, Kashentseva E, Rogers BE, Krasnykh V, Curiel DT (2000) Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells. J Virol 74:6875\u20136884","journal-title":"J Virol"},{"key":"3_CR24","first-page":"609","volume":"62","author":"EA Kashentseva","year":"2002","unstructured":"Kashentseva EA, Seki T, Curiel DT, Dmitriev IP (2002) Adenovirus targeting to c-erbB-2 oncoprotein by single-chain antibody fused to trimeric form of adenovirus receptor ectodomain. Cancer Res 62:609\u2013616","journal-title":"Cancer Res"},{"key":"3_CR25","doi-asserted-by":"publisher","first-page":"5354","DOI":"10.1158\/0008-5472.CAN-06-4679","volume":"67","author":"HJ Li","year":"2007","unstructured":"Li HJ, Everts M, Pereboeva L, Komarova S, Idan A, Curiel DT, Herschman HR (2007) Adenovirus tumor targeting and hepatic untargeting by a coxsackie\/adenovirus receptor ectodomain anti-carcinoembryonic antigen bispecific adapter. Cancer Res 67:5354\u20135361","journal-title":"Cancer Res"},{"key":"3_CR26","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1158\/2326-6066.CIR-14-0124-T","volume":"3","author":"A Kloos","year":"2015","unstructured":"Kloos A, Woller N, Gurlevik E, Ureche CI, Niemann J, Armbrecht N, Martin NT, Geffers R, Manns MP, Gerardy-Schahn R et al (2015) PolySia-specific retargeting of oncolytic viruses triggers tumor-specific immune responses and facilitates therapy of disseminated lung cancer. Cancer Immunol Res 3:751\u2013763","journal-title":"Cancer Immunol Res"},{"key":"3_CR27","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1158\/0008-5472.CAN-08-3209","volume":"69","author":"HJ Li","year":"2009","unstructured":"Li HJ, Everts M, Yamamoto M, Curiel DT, Herschman HR (2009) Combined transductional untargeting\/retargeting and transcriptional restriction enhances adenovirus gene targeting and therapy for hepatic colorectal cancer tumors. Cancer Res 69:554\u2013564","journal-title":"Cancer Res"},{"key":"3_CR28","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1128\/JVI.76.4.1892-1903.2002","volume":"76","author":"J Kim","year":"2002","unstructured":"Kim J, Smith T, Idamakanti N, Mulgrew K, Kaloss M, Kylefjord H, Ryan PC, Kaleko M, Stevenson SC (2002) Targeting adenoviral vectors by using the extracellular domain of the coxsackie-adenovirus receptor: improved potency via trimerization. J Virol 76:1892\u20131903","journal-title":"J Virol"},{"key":"3_CR29","doi-asserted-by":"publisher","first-page":"13743","DOI":"10.1128\/JVI.78.24.13743-13754.2004","volume":"78","author":"F Kuhnel","year":"2004","unstructured":"Kuhnel F, Schulte B, Wirth T, Woller N, Schafers S, Zender L, Manns M, Kubicka S (2004) Protein transduction domains fused to virus receptors improve cellular virus uptake and enhance oncolysis by tumor-specific replicating vectors. J Virol 78:13743\u201313754","journal-title":"J Virol"},{"key":"3_CR30","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1038\/sj.gt.3302103","volume":"10","author":"VW Beusechem van","year":"2003","unstructured":"van Beusechem VW, Mastenbroek DC, van den Doel PB, Lamfers ML, Grill J, Wurdinger T, Haisma HJ, Pinedo HM, Gerritsen WR (2003) Conditionally replicative adenovirus expressing a targeting adapter molecule exhibits enhanced oncolytic potency on CAR-deficient tumors. Gene Ther 10:1982\u20131991","journal-title":"Gene Ther"},{"key":"3_CR31","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/sj.cgt.7700606","volume":"10","author":"A Hemminki","year":"2003","unstructured":"Hemminki A, Wang M, Hakkarainen T, Desmond RA, Wahlfors J, Curiel DT (2003) Production of an EGFR targeting molecule from a conditionally replicating adenovirus impairs its oncolytic potential. Cancer Gene Ther 10:583\u2013588","journal-title":"Cancer Gene Ther"},{"key":"3_CR32","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","volume":"95","author":"TC He","year":"1998","unstructured":"He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 95:2509\u20132514","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Methods in Molecular Biology","Oncolytic Viruses"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-9794-7_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T00:54:05Z","timestamp":1610931245000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-9794-7_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,5]]},"ISBN":["9781493997930","9781493997947"],"references-count":32,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-9794-7_3","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4939-9794-7","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,5]]},"assertion":[{"value":"5 September 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}